ORMP

Oramed Pharmaceuticals Inc.$4.04-0.07 (-1.70%)

Prev Close$4.11·MCap$129.9M·P/E2.22·Vol51.4K·Yield0.08%

▲

Buys (12M)

$0.00

▼

Sells (12M)

$1.17M

◆

Net Activity

Net Seller

$1.17M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Oramed Pharmaceuticals Inc. (ORMP) has been exclusively selling, with 0 insider purchases totaling $0.00 and 4 insider sales totaling $1.17M. The most recent insider transaction was by Gabay Avraham (officer: Chief Financial Officer), who sold $90.2K worth of shares on Oct 2, 2026. Oramed Pharmaceuticals Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $129.9M.

ORMP Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 2, 2026	Gabay Avraham	officer: Chief Financial Officer	Sell	20,000	$4.51	$90.2K	861,076
Oct 2, 2026	Hexter Joshua	officer: COO & CBO	Sell	30,000	$4.51	$135.3K	1,328,130
Jul 2, 2026	Hexter Joshua	officer: COO & CBO	Sell	137,000	$4.46	$611.4K	1,023,384
Jul 2, 2026	Gabay Avraham	officer: Chief Financial Officer	Sell	73,360	$4.51	$330.7K	671,785
Apr 4, 2023	Mayer Arie	Director	Buy	8,809	$2.22	$19.5K	26,809+49%
Mar 16, 2023	KIDRON NADAV	President and CEO	Buy	26,000	$2.04	$53.0K	126,000+26%
Mar 15, 2023	Kidron Miriam	Chief Scientific Officer	Sell	100,000	$2.01	$201.0K	201,666-33%
Mar 15, 2023	KIDRON NADAV	President and CEO	Buy	100,000	$2.01	$201.0K	100,000
Mar 15, 2023	Rozov Yadin	Director	Buy	70,000	$2.02	$141.6K	86,500+424%
Jan 4, 2023	Rabinowitz Michael	Chief Commercial Officer	Sell	13,325	$12.55	$167.2K	138,043
May 10, 2022	Mayer Arie	Director	Sell	3,000	$25.60	$76.8K	0Exit
Mar 22, 2022	RAKIN KEVIN	Director	Sell	10,000	$9.41	$94.1K	46,661
Sep 20, 2021	RAKIN KEVIN	Director	Sell	21,100	$20.99	$442.8K	57,004-27%
Aug 11, 2021	KIDRON NADAV	President and CEO	Sell	220,000	$20.11	$4.42M0.6% OS	648,573-25%

ORMP Insider Buying Activity

The following table shows recent insider purchases of Oramed Pharmaceuticals Inc. (ORMP) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 4, 2023	Mayer Arie	Director	Buy	8,809	$2.22	$19.5K	26,809+49%
Mar 16, 2023	KIDRON NADAV	President and CEO	Buy	26,000	$2.04	$53.0K	126,000+26%
Mar 15, 2023	KIDRON NADAV	President and CEO	Buy	100,000	$2.01	$201.0K	100,000
Mar 15, 2023	Rozov Yadin	Director	Buy	70,000	$2.02	$141.6K	86,500+424%

ORMP Insider Selling Activity

The following table shows recent insider sales of Oramed Pharmaceuticals Inc. (ORMP) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 2, 2026	Gabay Avraham	officer: Chief Financial Officer	Sell	20,000	$4.51	$90.2K	861,076
Oct 2, 2026	Hexter Joshua	officer: COO & CBO	Sell	30,000	$4.51	$135.3K	1,328,130
Jul 2, 2026	Hexter Joshua	officer: COO & CBO	Sell	137,000	$4.46	$611.4K	1,023,384
Jul 2, 2026	Gabay Avraham	officer: Chief Financial Officer	Sell	73,360	$4.51	$330.7K	671,785
Mar 15, 2023	Kidron Miriam	Chief Scientific Officer	Sell	100,000	$2.01	$201.0K	201,666-33%
Jan 4, 2023	Rabinowitz Michael	Chief Commercial Officer	Sell	13,325	$12.55	$167.2K	138,043
May 10, 2022	Mayer Arie	Director	Sell	3,000	$25.60	$76.8K	0Exit
Mar 22, 2022	RAKIN KEVIN	Director	Sell	10,000	$9.41	$94.1K	46,661
Sep 20, 2021	RAKIN KEVIN	Director	Sell	21,100	$20.99	$442.8K	57,004-27%
Aug 11, 2021	KIDRON NADAV	President and CEO	Sell	220,000	$20.11	$4.42M0.6% OS	648,573-25%